|
|
Prepublished online as a Blood First Edition Paper on July 10, 2003; DOI 10.1182/blood-2003-05-1419.

Submitted May 6, 2003
Accepted June 30, 2003
Selective enhancement of multipotential hematopoietic progenitors in vitro and in vivo by IL-20
Ling Liu*, Chunjin Ding, Wei Zeng, Josef G Heuer, Jonathan W Tetreault, Timothy W Noblitt, Giao Hangoc, Scott Cooper, Kellie A Brune, Ganesh Sharma, Niles Fox, Scott W Rowlinson, Danise P Rogers, Derrick R Witcher, Peter K Lambooy, Victor J Wroblewski, James R Miller, and Hal E Broxmeyer
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA
Department of Microbiology and Immunology and The Walther Oncology Center, and The Walther Cancer Institute, Indiana University School of Medicine, Indianapolis, IN, USA
* Corresponding author; email: liu_ling{at}Lilly.com.
In a search for novel growth factors, we discovered that human IL-20 enhanced colony formation by CD34+ multipotential progenitors. IL-20 had no effect on erythroid, granulocyte-macrophage or megakaryocyte progenitors. IL-20 transgenic mice had increased numbers and cell cycling of multipotential, but not other progenitors. IL-20 administration to normal mice significantly increased only multipotential progenitor cells. This demonstrates that IL-20 significantly influences hematopoiesis, with specificity towards multipotential progenitors. This is the first cytokine with such specificity identified.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Wolk, K. Witte, E. Witte, S. Proesch, G. Schulze-Tanzil, K. Nasilowska, J. Thilo, K. Asadullah, W. Sterry, H.-D. Volk, et al.
Maturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytes
J. Leukoc. Biol.,
May 1, 2008;
83(5):
1181 - 1193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Sa, P. A. Valdez, J. Wu, K. Jung, F. Zhong, L. Hall, I. Kasman, J. Winer, Z. Modrusan, D. M. Danilenko, et al.
The Effects of IL-20 Subfamily Cytokines on Reconstituted Human Epidermis Suggest Potential Roles in Cutaneous Innate Defense and Pathogenic Adaptive Immunity in Psoriasis
J. Immunol.,
February 15, 2007;
178(4):
2229 - 2240.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-Y. Chen, B.-C. Cheng, M.-J. Jiang, M.-Y. Hsieh, and M.-S. Chang
IL-20 Is Expressed in Atherosclerosis Plaques and Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice
Arterioscler Thromb Vasc Biol,
September 1, 2006;
26(9):
2090 - 2095.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Donnelly, F. Sheikh, S. V. Kotenko, and H. Dickensheets
The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain
J. Leukoc. Biol.,
August 1, 2004;
76(2):
314 - 321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Sheikh, V. V. Baurin, A. Lewis-Antes, N. K. Shah, S. V. Smirnov, S. Anantha, H. Dickensheets, L. Dumoutier, J.-C. Renauld, A. Zdanov, et al.
Cutting Edge: IL-26 Signals through a Novel Receptor Complex Composed of IL-20 Receptor 1 and IL-10 Receptor 2
J. Immunol.,
February 15, 2004;
172(4):
2006 - 2010.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|